- Home
- XERS vs FUBO Comparison
XERS vs FUBO Comparison
Compare XERS & FUBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- FUBO
- Stock Information
- Founded
- XERS 2005
- FUBO 2009
- Country
- XERS United States
- FUBO United States
- Employees
- XERS N/A
- FUBO N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- FUBO Broadcasting
- Sector
- XERS Health Care
- FUBO Industrials
- Exchange
- XERS Nasdaq
- FUBO Nasdaq
- Market Cap
- XERS 500.2M
- FUBO 534.5M
- IPO Year
- XERS 2018
- FUBO 2020
- Fundamental
- Price
- XERS $3.47
- FUBO $1.36
- Analyst Decision
- XERS Buy
- FUBO Buy
- Analyst Count
- XERS 3
- FUBO 6
- Target Price
- XERS $4.87
- FUBO $2.88
- AVG Volume (30 Days)
- XERS 1.8M
- FUBO 12.8M
- Earning Date
- XERS 11-08-2024
- FUBO 11-01-2024
- Dividend Yield
- XERS N/A
- FUBO N/A
- EPS Growth
- XERS N/A
- FUBO N/A
- EPS
- XERS N/A
- FUBO N/A
- Revenue
- XERS $187,361,000.00
- FUBO $1,589,700,000.00
- Revenue This Year
- XERS $24.27
- FUBO $21.18
- Revenue Next Year
- XERS $18.57
- FUBO $11.64
- P/E Ratio
- XERS N/A
- FUBO N/A
- Revenue Growth
- XERS 22.72
- FUBO 24.45
- 52 Week Low
- XERS $1.69
- FUBO $1.10
- 52 Week High
- XERS $3.87
- FUBO $3.43
- Technical
- Relative Strength Index (RSI)
- XERS 54.75
- FUBO 38.68
- Support Level
- XERS $3.32
- FUBO $1.28
- Resistance Level
- XERS $3.57
- FUBO $1.44
- Average True Range (ATR)
- XERS 0.18
- FUBO 0.11
- MACD
- XERS -0.01
- FUBO -0.03
- Stochastic Oscillator
- XERS 42.86
- FUBO 15.32
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.
About FUBO fuboTV Inc.
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segment of the group is Streaming. It has a business presence in the United States and other international countries.